Takeda Pharmaceutical (TAK) Interest Coverage Ratio (2017 - 2026)

Takeda Pharmaceutical's Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.31 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 108.51% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 3.22 (up 33.15% YoY), while the FY2026 annual figure was 1.14, up 29.9% from the prior year.
• Interest Coverage Ratio was 0.31 for Q1 2026 at Takeda Pharmaceutical, up from 4.02 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.8 in Q1 2022 to a low of 6.58 in Q3 2024.
• Historically, Interest Coverage Ratio has averaged 2.93 across 5 years, with a median of 3.08 in 2023.
• The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio soared 124.71% in 2022, then slumped 14188.53% in 2025.
• A 5-year view of Interest Coverage Ratio shows it stood at 1.84 in 2022, then sank by 207.75% to 5.67 in 2023, then rose by 29.59% to 3.99 in 2024, then declined by 0.61% to 4.02 in 2025, then jumped by 107.77% to 0.31 in 2026.
• The last three Interest Coverage Ratio figures came in at 0.31 (Q1 2026), 4.02 (Q4 2025), and 3.3 (Q3 2025), per Business Quant data.